MARK A. BLINN - 19 Feb 2025 Form 4 Insider Report for TEXAS INSTRUMENTS INC (TXN)

Role
Director
Signature
/s/ Leslie Mba, Attorney in Fact
Issuer symbol
TXN
Transactions as of
19 Feb 2025
Transactions value $
-$113,408
Form type
4
Filing time
20 Feb 2025, 16:05:06 UTC
Previous filing
14 Feb 2025
Next filing
27 Aug 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXN Common Stock Options Exercise $415,798 +2,457 +21% $169.23 14,174 19 Feb 2025 Direct
transaction TXN Common Stock Options Exercise $329,342 +1,884 +13% $174.81 16,058 19 Feb 2025 Direct
transaction TXN Common Stock Options Exercise $187,853 +1,079 +6.7% $174.1 17,137 19 Feb 2025 Direct
transaction TXN Common Stock Options Exercise $128,243 +766 +4.5% $167.42 17,903 19 Feb 2025 Direct
transaction TXN Common Stock Sale -$1,174,645 -6,186 -35% $189.89 11,717 19 Feb 2025 Direct F1
holding TXN Common Stock 600 19 Feb 2025 Direct F2
holding TXN Common Stock 5,400 19 Feb 2025 By Trust F3
holding TXN Common Stock 5,400 19 Feb 2025 By Trust F4
holding TXN Common Stock 3,046 19 Feb 2025 By Trust F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXN NQ Stock Option (Right to Buy) Options Exercise $0 -2,457 -100% $0 0 19 Feb 2025 Common Stock 2,457 $169.23 Direct F6
transaction TXN NQ Stock Option (Right to Buy) Options Exercise $0 -1,884 -75% $0 628 19 Feb 2025 Common Stock 1,884 $174.81 Direct F7
transaction TXN NQ Stock Option (Right to Buy) Options Exercise $0 -1,079 -50% $0 1,080 19 Feb 2025 Common Stock 1,079 $174.1 Direct F8
transaction TXN NQ Stock Option (Right to Buy) Options Exercise $0 -766 -25% $0 2,300 19 Feb 2025 Common Stock 766 $167.42 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $189.75 to $190.105. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
F2 Shares are held in an irrevocable trust. The reporting person is the beneficiary.
F3 Shares held in Trust for the benefit of family member of which reporting person is trustee. Beneficial ownership by reporting person disclaimed.
F4 Shares held in Trust for the benefit of the reporting person. Reporting person is the sole trustee.
F5 Shares held in Trust for the benefit of family member; reporting person shares investment control. Beneficial ownership by reporting person disclaimed.
F6 The option became exercisable in four equal annual installments beginning on January 28, 2022.
F7 The option became exercisable in four equal annual installments beginning on January 27, 2023.
F8 The option became exercisable in four equal annual installments beginning on January 26, 2024.
F9 The option became exercisable in four equal annual installments beginning on January 25, 2025.